LNAI · Lunai Bioworks Inc
United States · RS rating 22 · As of 2026-10-14
| Price | 0.89 USD |
|---|---|
| 1-day change | -13.4% |
| RS rating (overall / 1M / 3M / 12M) | 22 / 2 / 3 / 25 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 23 / 31 / 33 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -161.5% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +79.2% |
| Market cap (USD) | $11.1M |